Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,264
Closed -$125K 2001
2020
Q3
$125K Buy
2,264
+39
+2% +$2.02K ﹤0.01% 1112
2020
Q2
$100K Sell
2,225
-305
-12% -$13.7K ﹤0.01% 1157
2020
Q1
$90K Hold
2,530
﹤0.01% 1464
2019
Q4
$90K Sell
2,530
-10,280
-80% -$382K ﹤0.01% 1464
2019
Q3
$447 Sell
12,810
-26,995
-68% -$1.04M ﹤0.01% 921
2019
Q2
$1.71K Sell
39,805
-33
-0.1% -$1.37K 0.01% 657
2019
Q1
$1.72K Buy
39,838
+36,517
+1,100% +$1.47M 0.01% 659
2018
Q4
$121 Buy
+3,321
New +$123K ﹤0.01% 1301
2018
Q3
Sell
-3,511
Closed -$135K 1748
2018
Q2
$135K Sell
3,511
-18,023
-84% -$663K ﹤0.01% 1177
2018
Q1
$706K Hold
21,534
﹤0.01% 853
2017
Q4
$706K Sell
21,534
-4,338
-17% -$149K ﹤0.01% 853
2017
Q3
$864K Sell
25,872
-701
-3% -$24.2K ﹤0.01% 791
2017
Q2
$815K Hold
26,573
﹤0.01% 810
2017
Q1
$815K Buy
+26,573
New +$819K ﹤0.01% 810

Other funds holding QGEN

Glenmede Trust's QGEN Position: Q4 2020 in Review

Glenmede Trust sold out of Qiagen (QGEN) in Q4 2020, closing a stake of 2,264 shares — an estimated $125K sold.

Glenmede Trust first reported a position in QGEN in Q1 2017 and held it in 14 quarters. The position peaked at $864K in Q3 2017. 268 funds tracked by Wall St. Rank hold QGEN as of Q4 2020.

  • Glenmede Trust reported no remaining Qiagen position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 2,264 Qiagen shares in Q4 2020, an estimated $125K.
  • Glenmede Trust first reported a position in Qiagen in Q1 2017 and held it in 14 quarters.
  • Glenmede Trust's Qiagen position peaked at $864K in Q3 2017.
  • 268 funds tracked by Wall St. Rank held Qiagen as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.